Portfolio company
Synteny
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops AI-based bioinformatic solutions and programmable protein therapeutics to help pharmaceutical and biotechnology firms discover treatments for immune-driven diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Synteny Biotechnology
The company develops generative AI platforms to design programmable protein therapeutics and precision immunology treatments for biotechnology researchers and pharmaceutical developers.
Evozyne
The company creates synthetic therapeutic proteins using generative artificial intelligence for pharmaceutical and biotechnology organisations to treat immune-mediated diseases and genetic disorders.
Synthekine
This company develops engineered cytokine therapeutics and protein engineering platforms for patients with cancer and autoimmune or inflammatory diseases.
Aikium
This company develops artificial intelligence and synthetic biology platforms to design and screen protein therapeutic libraries for biotechnology and pharmaceutical partners.
Immunara
This company develops biological foundation models and artificial intelligence to map immune system interactions for pharmaceutical and biotechnology researchers.
UbiquiTx
This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.
Aizen Therapeutics
This company develops oral peptide therapeutics for patients with chronic immune disorders using an artificial intelligence platform for molecular design.
Computational drug discovery platform
This company develops an AI-native platform for biologics discovery and engineering for biotechnology and pharmaceutical partners.
